image of Clinical Handbook of Psychotropic Drugs

Clinical Handbook of Psychotropic Drugs

Publication Year:
2021
Edition:
24th
Author:
Procyshyn, Ric M.; Bezchlibnyk-Butler, Kalyna Z.
Publisher:
Hogrefe Publishing GmbH
ISBN:
978-0-88-937593-2
Doody's Star Rating®:
Score:
85
Print/PDF
Request Info
Request Information
Access the Book in Ovid
Access the Book in Ovid
  • Description
  • Details
  • Collections
  • Also Recommended
Description
The standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.

Key features:
  • Independent, unbiased, up-to-date
  • Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
  • Succinct, bulleted information on all classes of medication: on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug
  • Potential interactions and side effects summarized in comparison charts
  • With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
  • Clearly written patient information sheets available for download as printable PDF files


This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.New for this edition
  • Neuroscience-based nomenclature – added to product availability tables
  • Antidepressants chapter includes new section on GABAA receptor positive modulator (brexanolone IV injection; trade name Zulresso)
  • Also covers Qelbree (viloxazine extended-release capsules), the first new ADHD medication approved by the FDA in over a decade; as well as updates to SSRI use in pregnancy and antidepressant augmentation strategies
  • Antipsychotics updates include revised dosing, especially adjustments in hepatic and renal impairment
  • Mood stabilisers chapter sections on lithium and anticonvulsants extensively revised
  • New formulations and trade names include: Adhansia XR (methylphenidate extended-release capsules), Caplyta(lumateperone), Dayvigo (lemborexant), Perseris (risperidone extended-release subcutaneous injection), Probuphine (buprenorphine subdermal implant), Propecia (finasteride tablets), Trelstar (triptorelin slow-release injection), Qelbree (viloxazine extended-release capsules)
Details
Platform:
OvidSP
Publisher:
Hogrefe Publishing GmbH
Product Type:
Book
Author:
Procyshyn, Ric M.; Bezchlibnyk-Butler, Kalyna Z.
ISBN:
978-0-88-937593-2
Specialty:
  • Psychiatry
  • Psychology
Language:
English
Edition:
24th
Pages:
0
Publication Year:
2021
Doody's Star Rating®:
Score:
85

Request Information

Rely on Ovid as the trusted solution that transforms research into results.
Back To Top